About the Company
DelMar Pharmaceuticals, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $DMPI News
KTRA Kintara Therapeutics, Inc.
Kintara Therapeutics, Inc. has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar ...
CRVS Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers ...
Questcor Pharmaceuticals,
Questcor Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders.
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead ...
Agios Pharmaceuticals Inc (AGIO) Stock Experiences -1.06% Monthly Change
AGIO stock has gone up by 1.36%, with a monthly decline of -1.06% and a quarterly surge of 37.64%. The volatility ratio for the week is 3.63%, and the volatility levels for the last 30 days are 3.67% ...
Elite Pharmaceuticals, Inc. (ELTP)
Elite Pharmaceuticals, Inc. (PNK:ELTP) Q3 2024 Earnings Call Transcript February 15, 2024 Elite Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...
Alnylam Pharmaceuticals Inc ALNY
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
TRACON Pharmaceuticals, Inc.
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin ...
Vertex Pharmaceuticals Inc VRTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
ANI Pharmaceuticals Inc
Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.
Agios Pharmaceuticals Inc (AGIO) Stock: Evaluating the Market Performance
Smart investors will not be hesitating on this one! Agios Pharmaceuticals Inc (NASDAQ: AGIO)’s stock price has soared by 2.30 in relation to previous closing price of 29.94. Nevertheless, the company ...
Stocks Mixed as Bond Yields Climb
The S&P 500 Index ($SPX) (SPY) is up +0.22%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.23%, and the Nasdaq 100 ...
Loading the latest forecasts...